Cortexyme (CRTX) Upgraded by Zacks Investment Research to Hold

Cortexyme} stock has undergone multiple analysts rating changes in the recent past.  Cortexyme Upgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Cortexyme (CRTX) Upgraded by Zacks Investment Research to Hold